| Product ID | 71800-901_19d5024a-b131-41c3-8cee-5e20564154aa |
| NDC | 71800-901 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sumatriptan and Naproxen Sodium |
| Generic Name | Sumatriptan And Naproxen Sodium |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-12-09 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA202803 |
| Labeler Name | Innovida Phamaceutique Corporation |
| Substance Name | SUMATRIPTAN SUCCINATE; NAPROXEN SODIUM |
| Active Ingredient Strength | 85 mg/1; mg/1 |
| Pharm Classes | Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC],Serotonin 1b Receptor Agonists [MoA],Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |